Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Assay request code ABO grouping E014 ABO, Rh and other antigen
Document related concepts
no text concepts found
Transcript
Assay ABO grouping ABO, Rh and other antigen typing problems absolute number of lymphocyte subpopulations Activated protein C resistance Acute Lymphocytic Leukemia Acute Myeloid Leukemia Acute Undifferentiated Leukemia Adalimumab (Humira), drug level Adalimumab (Humira), IgG antibodies against ADAMTS13 activity % ADAMTS13 antigen % ADCC test Albumin Alfa-1-foetoprotein Quantitative Alfa-2-antiplasmin activity % Alpha-1-antitrypsin + phenotype when <1.8 g/L Alpha-1-antitrypsin, concentration Alpha-1-antitrypsin, fenotype ANCA package (IIFT, anti-MPO and anti-PR3) anti-acetylcholine receptor (anti-AchR) anti-AchR if negative followed by anti-MuSK anti-ADAMTS13 anti-adrenoid gland anti-aquaporin 4 Anti-C1 inhibitor antibodies anti-cardiolipin IgM and IgG (ACL) anti-CMV IgG Quantitative anti-cornea anti-cyclic citrulinated peptide (anti-CCP) anti-Delta EIA Anti-DNAse B Anti-domain I ß2 glycoprotein I anti-dsDNA Farr assay anti-dsDNA PEG assay anti-dsDNA screening with immunofluorescence, if not negative followed by Farr assay anti-Exctractable Nuclear Antigens (ENA) Anti-factor IIa level (Dabigatran) Anti-factor Xa level (Rivaroxaban) anti-GAD65 anti-glomerular basement membrane (anti-GBM) anti-hart muscle anti-HAV anti-HBc anti-HBc IgM anti-HBe anti-HBs Quantitative anti-HCV anti-Histon anti-HTLV I/II anti-IA-2 anti-intrinsic factor anti-Islands of Langerhans anti-liver/kidney microsomal antibodies 1 (anti-LKM-1) anti-Mitochondria antibodies (AMA) anti-Muscle-Specific Kinase (anti-MuSK) request code E014 E910 P006 H950 P901 P002 P903 J291 J290 H063 H068 E905 S1025 V003 H044 S910 S1028 S012 A908 A011 A901 H065 A009 A019 C015 A035 V1212 A015 A045 V1031 S046 H088 A027 A028 A026 A031 H086 H087 A049 A917 A012 V1124 V1196 V1201 V1200 V1190 V1198 A034 V1214 A050 A002 A018 A044 A005 A048 Anti-Myeloperoxidase (anti-MPO) A029 Antinuclear antibodies (ANA) A925 A903 anti-parietal cell antibodies A053 anti-Phospholipase-A2-receptor (anti-PLA2R) Anti-Proteinase 3 (anti-PR3) A030 A051 anti-Solubel Liver antigen (anti-SLA/LP) anti-ß2 glycoprotein I IgG/IgM H029 Anti-streptolysin titer (AST) S044 A021 anti-striated muscle Anti-Syfilis V1193 Antithrombin activity % H026 Antithrombin antigen % H027 A056 anti-thyroglobulin (anti-Tg) A057 anti-thyroperoxidase (anti-TPO) A038 anti-TSH receptor A016 anti-tubular basement membrane A025 anti-Zinc ransporter 8 (anti-ZnT8) AP50 titer C011 APTT sec. H001 Aspergillus, precipitating antibodies against Z255 atypical hemolytic uremic syndrome package (complement C3, complement factor I, compleC023 Autoimmune granulocytopenia T913 Autoimmune Haemolytic Disease E921 P029 BCR-ABL fusiontranscript (CML diagnosis) P003 BCR-ABL fusiontranscript (CML therapy monitoring) Z205 Bee venom, blocking antibodies Z202 Bee venom, blocking antibodies, assay including previous serum sample Bèta-2-microglobulin S015 Z190 Birch pollen, blocking antibodies Z187 Birch pollen, blocking antibodies, assay including previous serum sample C1 inhibitor activity, if decreased also complement C4 C913 C1-inhibitor antigen (Vista) C604 C1-inhibitor concentration in C1-inhibitor concentrate Y012 C012 C3 "nephritic" factor C3d C009 Z260 Canary, precipitating antibodies against Z258 Candida albicans, precipitating antibodies against Z175 Cat, blocking antibodies Cat, blocking antibodies, assay including previous serum sample Z172 P052 CEBPa mutation analysis Celiac disease screening R344 J304 Certolizumab, drug level Certolizumab, IgG antibodies against J303 Ceruloplasmin S017 CH50 titer C010 Z267 Chicken serum, precipitating antibodies against chromosomal aberrations in CLL P044 P011 Chronic Lymphocytic Leukemia H021 Circulating anticoagulants circulating immune complexes (C1q-binding) C001 P045 CLL (flowcytometry, SHM, chr. aberrations) complement C1q C030 complement C1q, antibodies against C018 complement C2 C017 complement C3 C035 complement C4 C036 complement C4 polymorphism complement C5 complement C9 Complement deficiency, identification of (with absent complement activity) complement factor B complement factor H complement factor H activity Configuration T-cell receptor genes Cows milk, precipitating antibodies against Coxiella burnetii IgG fase II ELISA Cryoglobulin, qualitatively Cryoglobulin, typing cytotoxic T-lymphocytes D-Dimer deamidated gliadin, IgA antibodies deamidated gliadin, IgG antibodies DNA isolation and storage DNA-analysis alpha-thalassemia Dog, blocking antibodies Drug-induced haemolysis Drug-induced thrombocytopenia erythrocytic enzymes Etanercept (Enbrel), drug level Etanercept (Enbrel), IgG antibodies against EVI1 overexpression Factor II activity concentrate IU/mL Factor II antigen % Factor IX activity % Factor IX activity concentrate IU/mL Factor IX activity plasma IU/mL Factor IX antigen % Factor IX, antibodies against- Beth.U/mL Factor IXa activity mIU/mL Factor V (Leiden) 1691G>A mutation Factor V activity % Factor V antigen % Factor VII activity % Factor VII activity concentrate IU/mL Factor VII activity IU/mL Factor VIII activity % Factor VIII activity concentrate IU/mL Factor VIII activity plasma IU/mL Factor VIII antigen % Factor VIII, antibodies against- Beth.U/mL Factor X activity % Factor X activity concentrate IU/mL Factor X antigen % Factor XI activity % Factor XII activity % Factor XIII activity % Fetal HPA-1a genotyping, non-invasive with ffDNA Fetal RHD typing, non-invasive with ffDNA Fetal/neonatal granulocytopenia Fetal/neonatal thrombocytopenia Fibrinogen antigen g/L Fibrinogen functional g/L C019 C007 C022 C014 C008 C020 C021 P025 Z263 V1240 S620 S621 P008 H071 R342 R343 W054 B003 Z285 E922 T907 B005 J295 J294 P050 H061 H047 H016 H769 H720 H017 H024 H744 H051 H008 H054 H009 H717 H030 H011 H718 H726 H012 H025 H010 H062 H048 H018 H019 H020 T012 E043 T914 T911 H005 H006 Fibrinogen qualitative FII activity % FLT3-ITD Fragment 1,2 Free light chains kappa, serum (N-FLC Siemens) Free light chains kappa, urine (N-FLC Siemens) Free light chains lambda, serum (N-FLC Siemens) Free light chains lambda, urine (N-FLC Siemens) Free light chains ratio, serum (N-FLC Siemens) Free light chains ratio, urine (N-FLC Siemens) fusiontranscript AML1-ETO in AML M2 fusiontranscript BCL1-IgH in Mantle Cell Lymphoma fusiontranscript BCL2-IgH in Follicular Lymphoma fusiontranscript BCR-ABL, mutation analysis causing therapyresistance fusiontranscript CBFB-MYH11 in AML M4 eo fusiontranscript NPM1-ALK in anaplastic large cell NHL fusiontranscript PML-RARA in promyelocytic leukemia fusiontranscript TEL-AML1 in ALL fusiontranscripts MLL-AF4, BCR-ABL and TEL-AML1 in pre B-ALL FXII genotyping HAE type III Genotyping Blood group antigens GM-CSF, antibodies against Golimumab, drug level Golimumab, IgG antibodies against Graspollen, blocking antibodies Grass pollen, blocking antibodies, assay including previous serum sample Haemolysis, investigation immune/non-immune Haemolytic transfusion reaction Hairy Cell Leukemia Haptoglobin HBeAg HBsAg HBsAg Quantitative HBV-DNA genotyping HBV-DNA Quantitative HCV confirmation HCV-RNA genotyping HCV-RNA Quantitative Hemoglobin analysis Hemoglobin typing (HbA2 and HbF quantitative) Heparin Induced Platelet Activation Assay Heparin-induced thrombocytopenia heriditary sferocytosis (spectrin, EMA and AGLT) HEV PCR HIV Ag/Ab Combo HIV, HBV, HCV Multiplex assay HIV-1/2 confirmation HIV-antigeen p24 HIV-RNA Quantitative HLA class & class II cytotoxic cross match HLA class I & II antibody detection & specification by means of Luminex technique HLA class I antibody detection HLA class I low resolution DNA typing HLA class II low resolution DNA typing HLA-A* high resolution typing HLA-A* low resolution DNA typing H725 H007 P043 H070 S049 S051 S050 S052 S047 S048 P038 P036 P009 P048 P034 P037 P031 P054 P030 H066 E042 R420 J306 J305 Z157 Z154 E920 E913 P914 S028 V1199 V1195 V1234 V1203 V1217 V1246 V1044 V1215 B002 B010 T041 T040 B009 V1241 V1197 V1223 V1005 V1116 V1220 W001 W014 W004 W009 W010 W032 W040 HLA-A*,-B*,-C* high resolution DNA typing HLA-B* high resolution DNA typing HLA-B* low resolution DNA typing HLA-B*57 high resolution DNA typing HLA-B27 DNA confirmatory typing HLA-C* high resolution DNA typing HLA-C* low resolution DNA typing HLA-DPB1* high resolution DNA typing HLA-DQ2/DQ8 DNA typing HLA-DQA1* low resolution DNA typing HLA-DQB1* high resolution DNA typing HLA-DQB1* low resolution DNA typing HLA-DRB1* high resolution DNA typing HLA-DRB1* low resolution DNA typing HLA-DRB1*,-DQB1* high resolution DNA typing HLA-DRB3,4,5 high resolution DNA typing HLA-DRB3,4,5 low resolution DNA typing HLA-H mutation analysis House Dust Mite, blocking antibodies House Dust Mite, blocking antibodies, assay including previous serum sample HPA genotyping HTLV I/II confirmation IFN-gamma, Quantitative, Quantiferon IgA IgA (low concentration) in IgG concentrate IgA anti-endomysial antibodies (EMA) IgA in IgG concentrate IgA subclasses IgA, antibodies against IgA, if conc. <0.02 g/L also anti-IgA antibodies IgD IgG anti-endomysial antibodies (EMA) IgG anti-HEV EIA IgG determinded in dried blood spot (finger prick) IgG in IgG concentrate IgG subclasses IgG1 IgG1 in IgG concentrate IgG2 IgG2 in IgG concentrate IgG3 IgG3 in IgG concentrate IgG4 IgG4 in IgG concentrate IgM IgM aHAV IgM anti-HEV EIA IgM in IgG concentrate IL-6 Immune thrombocytopenia Infliximab (Remicade), drug level Infliximab (Remicade), IgG antibodies against JAK2 exon 12 mutation analysis JAK-2 V617F mutation Kleihauer-Betke test Lectin Pathway activity W013 W030 W041 W031 W011 W033 W042 W024 W006 W046 W048 W044 W047 W043 W008 W049 W045 B017 Z163 Z160 T021 V1113 V052 S1026 Y025 A037 Y001 S007 S027 S902 S005 A039 V1046 S010 Y003 S006 S061 Y004 S062 Y005 S063 Y006 S064 Y007 S1027 V1123 V1047 Y002 A003 T922 J289 J288 P902 P920 E003 C016 Luminex Single Antigen HLA class I antibody analysis Luminex Single Antigen HLA class II antibody analysis Lupus anticoagulant/anti-phospholipids Lymphocyte subpopulations (NHL, e.d) Lymphocytosis M protein typing M. Waldenström Mannose binding lectin (MBL) Micropolyspora faeni, precipitating antibodies against monoclonal B-cell population monoclonal T-cell population M-protein total: IgG/M/A + zone-electrophoresis + typing M-protein MTHFR 677C>T mutation Multiple Myeloma Myelodysplasia myositis associated antibodies naive and memory T-lymphocytes Natalizumab (Tysabri), drug level Natalizumab, IgG antibodies against Non activated partial thromboplastin time, NAPTT Non-Hodgkin Lymphoma NPM1 mutation analysis Omalizumab, IgG antibodies against p-ANCA (inflammatory bowl disease, only IIFT) Paroquet, precipitating antibodies against Parrot, precipitating antibodies against Parvo_B19 DNA Quantitative Pigeon, precipitating antibodies against Plasminogen activity % Plasminogen antigen % Platelet function testing Platelet transfusion refractoriness PNH Pro Lymphocytic Leukemia prognostic molecular screening AML diagnosis Protein C activity % Protein C antigen % Protein S free antigen % Protein S total antigen % Proteine C activity IU/mL Proteine S antigen U/mL Prothrombin 20210G>A mutation Prothrombin time sec. Red cell antibody identification RhD typing rheumatoid factor Rituximab (Mabthera), drug level Rituximab (Mabthera), IgG antibodies against scleroderma associated antibodies skin disease antibodies (anti-dsg1, anti-dsg3, antiBP180, anti-BP230) Smooth Muscle antibodies (SMA) Somatic Hyper Mutation status in CLL Steroid-producing cell autoantibodies (ovary tissue IIFT only) Syphilis confirmation T-gamma (NK-cell) lymphocytosis Thermoactinomyces vulgaris, precipitating antibodies against W034 W035 H022 P032 P904 S022 P915 S029 Z256 P917 P918 S021 H058 P916 P021 A052 P007 J299 J307 H713 P910 P051 J308 A055 Z262 Z261 D1012 Z259 H041 H042 H060 T902 E027 P912 P042 H928 H929 H931 H930 H734 H736 H057 H003 E911 E013 A042 J293 J292 A020 A014 A004 P908 A054 V1136 P919 Z257 Thrombin time Thrombin-antithrombin complex Thrombocytopenia tissue transglutaminase, IgA antibodies tissue transglutaminase, IgG antibodies TNF-alpha Tocilizumab, IgG antibodies against Total protein concentration TPO measurement Transferrin Transfusion Related Acute Lung Injury Trastuzumab (Herceptin), drug level Ustekinumab (Stelara), IgG antibodies against Von Willebrand factor activity % Von Willebrand factor antigen % Von Willebrand factor genotyping Von Willebrand factor multimers Von Willebrand factor propeptide % Wasp Venom, blocking antibodies Wasp venom, blocking antibodies, assay including previous serum sample X-match problems H004 H072 T912 R405 R407 A008 J310 S035 T023 S018 T903 J298 J133 H013 H014 H059 H015 H055 Z196 Z193 E912 For questions on required materials, pricing and logistics, please contact us at Diagnostic.Services@sa To request a test, please complete form 30 for each sample. Depict the assay name and request code Send the form, together with the sample, to Sanquin, using the address as depicted on the request form anquin.n as indicated in this table m
Related documents